Last reviewed · How we verify

NCT05873582: RAS-Ahead

Robotic Minimally Invasive Inguinal Hernia Repair With Dexter

Completed Last updated 5 January 2024
What this trial tests

trial testing Robotic-assisted inguinal hernia repair in Inguinal Hernia Repair in 50 participants. Completed in 23 October 2023.

Timeline
2 June 2023
Primary endpoint
23 October 2023
23 October 2023

Quick facts

Lead sponsorDistalmotion SA
StatusCompleted
Study typeOBSERVATIONAL
Enrollment50
Start date2 June 2023
Primary completion23 October 2023
Estimated completion23 October 2023
Sites3 locations across France, Switzerland, Germany

Drugs / interventions tested

Conditions studied

Sponsor

Distalmotion SA

Who can join

18 and older, any sex, with Inguinal Hernia Repair. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to confirm the perioperative and early postoperative safety and clinical performance (efficacy) of the Dexter Robotic System, in patients undergoing primary transperitoneal unilateral or bilateral inguinal hernia repair.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Robotic minimally invasive inguinal hernia repair with the Dexter robotic system™: A prospective multicenter clinical investigation.
    Gantner L, Mignot H, Pochhammer J, Grieder F, et al · · 2024 · cited 3× · PMID 39542890 · DOI 10.1007/s00464-024-11361-1

Verify or expand the search:

Other trials of Robotic-assisted inguinal hernia repair

Trials testing the same drug.

Other recruiting trials for Inguinal Hernia Repair

Currently open trials in the same condition.

Other Distalmotion SA trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05873582.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing